Clinical utility of linear endosonography in patients with unexplained biliary dilatation and negative MRCP, with predictors for detection of neoplastic lesions

Egyptian Liver Journal

Table 1 Patient characteristics

	Number	Percentage
Age/years	60 (21–82)
Sex
• Male	29	47.5
• Female	32	52.6
Clinical presentation
• Jaundice	43	70.5
• Upper abdominal pain	10	16.4
• Incidental biliary dilatation	8	13.1
History of cholecystectomy	6	9.8
Laboratory data
• Bilirubin (total) (mg/dl)	2.8 (0.4–39)
• ALT (IU/l)	49 (11–293)
• AST (IU/l)	47 (19–288)
• Alkaline phosphatase (mg/dl)	223.0 (47–1260 )
• Tumor markers
CA19-9	39.0 (0.60–1200)
CEA	2.69 (0.4–15.05)

Data are expressed as mean ± SD, median (range), or n (%)
ALT Alanine transaminase, AST Aspartate aminotransferase, CA19-9 Carbohydrate antigen 19-9, CEA Carcinoembryonic antigen